Clinical and survival impact of FDG PET in patients with suspicion of recurrent cervical carcinoma.
Pallardy A, Bodet-Milin C, Oudoux A, Campion L, Bourbouloux E, Sagan C, Ansquer C, Testard A, Resche I, Bridji B, Kraeber-Bodéré F, Rousseau C.
Pallardy A, et al. Among authors: ansquer c.
Eur J Nucl Med Mol Imaging. 2010 Jul;37(7):1270-8. doi: 10.1007/s00259-010-1417-1. Epub 2010 Mar 20.
Eur J Nucl Med Mol Imaging. 2010.
PMID: 20306032